CCR 20th Anniversary Commentary: Autologous T Cells-The Ultimate Personalized Drug for the Immunotherapy of Human Cancer

被引：6
|
作者：
Rosenberg, Steven A. [1 ]
机构：
[1] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA
来源：
CLINICAL CANCER RESEARCH | 2015年 / 21卷 / 24期
关键词：
TUMOR-INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA; RECOMBINANT INTERLEUKIN-2; ADOPTIVE IMMUNOTHERAPY; ANTIGENS; REGRESSION; THERAPY;
D O I：
10.1158/1078-0432.CCR-14-3131
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The article by Rosenberg and colleagues, which was published in the July 1, 2011, issue of Clinical Cancer Research, demonstrated the power of the adoptive transfer of autologous antitumor T cells to mediate the complete, durable, and likely curative regression of cancer in patients with heavily pretreated metastatic melanoma. It also provided a stimulus to the development of cell transfer approaches for other cancer types using both natural and genetically engineered lymphocytes. (C)2015 AACR.
引用
收藏
页码：5409 / 5411
页数：3
相关论文
共 32 条
  • [31] Human CCR4+CCR6+Th17 Cells Suppress Autologous CD8+ T Cell Responses
    Zhao, Fei
    Hoechst, Bastian
    Gamrekelashvili, Jaba
    Ormandy, Lars A.
    Voigtlaender, Torsten
    Wedemeyer, Heiner
    Ylaya, Kris
    Wang, Xin Wei
    Hewitt, Stephen M.
    Manns, Michael P.
    Korangy, Firouzeh
    Greten, Tim F.
    JOURNAL OF IMMUNOLOGY, 2012, 188 (12): : 6055 - 6062
  • [32] THE DEVELOPMENT OF IMMUNOTHERAPY FOR CANCER - A CITATION-CLASSIC COMMENTARY ON OBSERVATIONS ON THE SYSTEMIC ADMINISTRATION OF AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER-CELLS AND RECOMBINANT INTERLEUKIN-2 TO PATIENTS WITH METASTATIC CANCER BY ROSENBERG,S.A., LOTZE,M.T., MUUL,,L.M., LEITMAN,S., CHANG,A.E., ETTINGHAUSEN,S.E., MATORY,Y.L., SKIBBER,J.M., SHILONI,E., VETTO,J.T., SEIPP,C.A., SIMPSON,C. AND REICHERT,C.M.
    ROSENBERG, SA
    CURRENT CONTENTS/CLINICAL MEDICINE, 1993, (16) : 8 - 8
1234